{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:17:44Z","timestamp":1790957864873,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A120004"],"award-info":[{"award-number":["A120004"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A120004"],"award-info":[{"award-number":["A120004"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jpsychires.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T09:45:48Z","timestamp":1392457548000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["A review of current evidence for acetyl-l-carnitine in the treatment of depression"],"prefix":"10.1016","volume":"53","author":[{"given":"Sheng-Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin A.","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash S.","family":"Masand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Un","family":"Pae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2014.02.005_bib1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuroscience.2008.10.041","article-title":"Acetyl-l-carnitine provides effective in\u00a0vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain","volume":"158","author":"Alves","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1007501306623","article-title":"Effect of long-term feeding with acetyl-l-carnitine on the age-related changes in rat brain lipid composition: a study by 31P NMR spectroscopy","volume":"25","author":"Aureli","year":"2000","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.biopsych.2009.08.033","article-title":"Epigenetics in suicide and depression","volume":"66","author":"Autry","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/15622975.2013.804195","article-title":"World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders","volume":"14","author":"Bauer","year":"2013","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib5","first-page":"355","article-title":"Effect of acetyl-l-carnitine on geriatric patients suffering from dysthymic disorders","volume":"10","author":"Bella","year":"1990","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/WNF.0b013e31828ef969","article-title":"Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study","volume":"36","author":"Bergman","year":"2013","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.euroneuro.2012.11.013","article-title":"l-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine","volume":"23","author":"Bersani","year":"2013","journal-title":"European Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib8","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.1523\/JNEUROSCI.1309-11.2011","article-title":"Vulnerability to depression: from brain neuroplasticity to identification of biomarkers","volume":"31","author":"Blugeot","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/JCP.0b013e31829a83f5","article-title":"A\u00a0placebo-controlled trial of acetyl-l-carnitine and alpha-lipoic acid in the treatment of bipolar depression","volume":"33","author":"Brennan","year":"2013","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.urology.2003.11.009","article-title":"Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging","volume":"63","author":"Cavallini","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuropharm.2012.05.022","article-title":"mGlu2\/3 and mGlu5 receptors: potential targets for novel antidepressants","volume":"66","author":"Chaki","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.dld.2007.06.013","article-title":"l-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study","volume":"39","author":"Ciacci","year":"2007","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jpainsymman.2006.09.001","article-title":"Safety, tolerability and symptom outcomes associated with l-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I\/II study","volume":"32","author":"Cruciani","year":"2006","journal-title":"The Journal of Pain and Symptom Management"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib14","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/npp.2013.121","article-title":"Upregulation of mGlu2 receptors via NF-kappaB p65 acetylation is involved in the proneurogenic and antidepressant effects of acetyl-l-carnitine","volume":"38","author":"Cuccurazzu","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.neuroscience.2009.11.021","article-title":"The neuropathy-protective agent acetyl-l-carnitine activates protein kinase C-gamma and MAPKs in a rat model of neuropathic pain","volume":"165","author":"Di Cesare Mannelli","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-011-2326-0","article-title":"Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression","volume":"218","author":"Di Cesare Mannelli","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jagp.2013.01.014","article-title":"Reduced serum nerve growth factor in patients with late-life depression","volume":"21","author":"Diniz","year":"2013","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.genhosppsych.2007.06.002","article-title":"Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability","volume":"29","author":"Egede","year":"2007","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib19","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","article-title":"Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis","volume":"45","author":"Fernandes","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0278-5846(94)00109-U","article-title":"Effects of acetyl-l-carnitine treatment and stress exposure on the nerve growth factor receptor (p75NGFR) mRNA level in the central nervous system of aged rats","volume":"19","author":"Foreman","year":"1995","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(95)00234-C","article-title":"A\u00a0pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635","volume":"281","author":"Forster","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib22","first-page":"155","article-title":"Laevo-acetylcarnitine (NicetileR) treatment of senile depression","volume":"27","author":"Fulgente","year":"1990","journal-title":"Journal of the Society for Clinical Trials"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib23","first-page":"101","article-title":"Evaluation of the effects of l-acetylcarnitine on senile patients suffering from depression","volume":"16","author":"Garzya","year":"1990","journal-title":"Drugs Under Experimental and Clinical Research"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib24","first-page":"333","article-title":"Acetyl-l-carnitine in aged subjects with major depression: clinical efficacy and effects on the circadian rhythm of cortisol","volume":"2","author":"Gecele","year":"1991","journal-title":"Dementia"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hipo.20672","article-title":"Blockade of insulin-like growth factor-I has complex effects on structural plasticity in the hippocampus","volume":"20","author":"Glasper","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1586\/ern.12.92","article-title":"Can botulinum toxin improve mood in depressed patients?","volume":"12","author":"Han","year":"2012","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14737175.2013.811901","article-title":"Second-generation antipsychotics in the treatment of major depressive disorder: current evidence","volume":"13","author":"Han","year":"2013","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0005-2760(74)90164-7","article-title":"The effect of myo-inositol deficiency on lipid metabolism in rats. II. The mechanism of triacylglycerol accumulation in the liver of myo-inositol-deficient rats","volume":"360","author":"Hayashi","year":"1974","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.neuroscience.2005.03.051","article-title":"The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity","volume":"135","author":"Hayley","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4088\/JCP.v66n0812","article-title":"An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder","volume":"66","author":"Iosifescu","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/aje\/kwr472","article-title":"Cross-sectional but not longitudinal association between n-3 fatty acid intake and depressive symptoms: results from the SU.VI.MAX 2 study","volume":"175","author":"Kesse-Guyot","year":"2012","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib33","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib34","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4088\/JCP.12m07706","article-title":"Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study","volume":"73","author":"Khajavi","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1471-4159.2001.00621.x","article-title":"Functional relevance of carnitine transporter OCTN2 to brain distribution of l-carnitine and acetyl-l-carnitine across the blood-brain barrier","volume":"79","author":"Kido","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S1461145704004596","article-title":"Effect of intraperitoneal acetyl-l-carnitine (ALCAR) on anxiety-like behaviours in rats","volume":"8","author":"Levine","year":"2005","journal-title":"The international Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v69n0610","article-title":"Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3109\/00365521.2011.565067","article-title":"Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy","volume":"46","author":"Malaguarnera","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.pnpbp.2011.01.013","article-title":"Acetyl-l-carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects","volume":"35","author":"Martinotti","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib40","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1098\/rstb.2012.0212","article-title":"Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression","volume":"367","author":"Massart","year":"2012","journal-title":"Philosophical Transactions of the Royal Society of London"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuropharm.2008.05.014","article-title":"Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats","volume":"55","author":"Matrisciano","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib42","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.mp.4002005","article-title":"Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?","volume":"12","author":"Matrisciano","year":"2007","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib43","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-3565(24)37878-4","article-title":"Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats","volume":"287","author":"Nakamura","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib44","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1073\/pnas.1216100110","article-title":"L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors","volume":"110","author":"Nasca","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib45","first-page":"225","article-title":"Action of acetyl-l-carnitine in association with mianserine on depressed old people","volume":"3","author":"Nasca","year":"1989","journal-title":"New Trends in Clinical Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib46","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0006-3223(95)00599-4","article-title":"Serum lipid concentrations in patients with major depressive disorder","volume":"40","author":"Olusi","year":"1996","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jpsychires.2008.01.010","article-title":"Altered expression of neurotrophic factors in patients with major depression","volume":"42","author":"Otsuki","year":"2008","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/WNF.0b013e318290b8c8","article-title":"Scopolamine as an antidepressant","volume":"36","author":"Pae","year":"2013","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/WNF.0b013e3182aa8cab","article-title":"Curcumin as an add-on to antidepressive treatment","volume":"36","author":"Pae","year":"2013","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/11538980-000000000-00000","article-title":"Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data","volume":"25","author":"Pae","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biopha.2007.12.005","article-title":"Does minocycline have antidepressant effect?","volume":"62","author":"Pae","year":"2008","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/070674371205700703","article-title":"Folates and S-adenosylmethionine for major depressive disorder","volume":"57","author":"Papakostas","year":"2012","journal-title":"The Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib53","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jpsychires.2005.04.013","article-title":"Adjunctive atomoxetine for residual fatigue in major depressive disorder","volume":"40","author":"Papakostas","year":"2006","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib54","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/appi.ajp.2012.11071114","article-title":"L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials","volume":"169","author":"Papakostas","year":"2012","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00314926","article-title":"Pharmacokinetics of IV and oral acetyl-l-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type","volume":"42","author":"Parnetti","year":"1992","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","article-title":"Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients","volume":"43","author":"Peet","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib57","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0237-07.2007","article-title":"Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates","volume":"27","author":"Perera","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1399-5618.2002.01180.x","article-title":"31P-MRS study of acetyl-l-carnitine treatment in geriatric depression: preliminary results","volume":"4","author":"Pettegrew","year":"2002","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib59","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.mp.4000805","article-title":"Acetyl-l-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression","volume":"5","author":"Pettegrew","year":"2000","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib61","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0163-1047(90)91296-N","article-title":"Acetylcarnitine reduces the immobility of rats in a despair test (constrained swim)","volume":"54","author":"Pulvirenti","year":"1990","journal-title":"Behavioral and Neural Biology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib62","first-page":"182","article-title":"Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients","volume":"25","author":"Rossini","year":"2007","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib64","article-title":"Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial","author":"Sanmukhani","year":"2013","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib65","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuint.2012.04.008","article-title":"Chronic acetyl-l-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice","volume":"61","author":"Smeland","year":"2012","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib67","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1212\/WNL.41.11.1726","article-title":"Long-term acetyl-l-carnitine treatment in Alzheimer's disease","volume":"41","author":"Spagnoli","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.mam.2004.06.006","article-title":"Carnitine: a nutritional, biosynthetic, and functional perspective","volume":"25","author":"Steiber","year":"2004","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib69","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0026-0495(96)90161-4","article-title":"Acetyl-l-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat","volume":"45","author":"Stevens","year":"1996","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.jpsychires.2014.02.005_bib70","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1517\/13543784.2013.836487","article-title":"Omega-3 polyunsaturated fatty acids for major depressive disorder","volume":"22","author":"Su","year":"2013","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib71","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-010-0452-1","article-title":"Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders","volume":"117","author":"Takebayashi","year":"2010","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib72","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0893-133X(02)00306-8","article-title":"Effects of long-term acetyl-l-carnitine administration in rats: I. increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure","volume":"27","author":"Tolu","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2003.11.005","article-title":"Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial","volume":"218","author":"Tomassini","year":"2004","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib75","first-page":"1","article-title":"Acetyl-l-carnitine in depressed geriatric patients","volume":"6","author":"Villardita","year":"1993","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.jpsychires.2014.02.005_bib76","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.euroneuro.2005.10.005","article-title":"A\u00a0double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia","volume":"16","author":"Zanardi","year":"2006","journal-title":"European Neuropsychopharmacol"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395614000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395614000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:09:24Z","timestamp":1758366564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395614000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":76,"alternative-id":["S0022395614000454"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.02.005","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of current evidence for acetyl-l-carnitine in the treatment of depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}